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RBC Characteristics and Cardiac Surgery Patients
RBCs on the resulting quality of circulating RBCs has not been described.
One measure of RBC quality is cell membrane deformability or the ability for the cell to elongate when exposed to shear stress while being forced through a thin channel (microfluidic slit-flow ektacytometry). 33, 34 Using this method, we have previously shown that both fresh RBCs drawn directly from untransfused patients, as well allogeneic RBC stored for shorter duration (<21 days), have a greater elongation index (average approximately 0.33), compared with RBCs stored for ≥21 days (average approximately 0.28). 26 RBC cell membrane elasticity and the ability to change shape are necessary for the cells to pass through small capillaries that can be smaller in diameter (5-10 μm) than the RBCs themselves (approximately 6-8 μm). 35, 36 Impaired RBC cell membrane deformability is associated with "entrapment and blockage" in the microcirculation, as well as reduced regional blood flow and reduced oxygen delivery. 31, 37 In the current prospective observational cohort study, we assessed RBC deformability and aggregation before and after CPB in patients who received autologous salvaged blood, with or without stored allogeneic blood. The primary hypothesis being tested was that CPB with autologous salvaged blood alone has minimal effects on circulating RBCs, whereas the addition of transfused stored allogeneic blood is associated with dose-dependent adverse changes in RBC deformability and aggregation.
METHODS
Patient and Anesthetic Management
After receiving IRB approval (The Johns Hopkins Medical Institutions) and written informed consent, we enrolled 32 patients undergoing cardiac surgery with or without concomitant ascending aortic repair between July 2012 and July 2013. Inclusion criteria were the planned use of CPB and autologous blood salvage. Exclusion criteria included sickle cell disease or other known RBC disorders and the refusal of blood transfusion.
Intraoperative care was standardized, and all patients received general anesthesia with a combination of midazolam, fentanyl, and isoflurane with vecuronium given for muscle relaxation. Ventilatory goals were to maintain normocapnia during surgery. Heparin (350 IU/kg) was used for anticoagulation, which was monitored by the kaolin-activated clotting time and maintained at a level of >480 seconds. The extracorporeal circuit consisted of roller pumps (Terumo, Tokyo, Japan), a hollow fiber membrane oxygenator (Sorin, Milan, Italy), and a standard arterial line filter (Sorin). The priming consisted of 1600 mL of lactated Ringer's solution and a retrograde autologous prime of 700 mL. Pump flow was adjusted to 2.2 L/m 2 /min. Nasopharyngeal temperature during CPB was maintained at 32°C, followed by rewarming to a urinary bladder temperature ≥35°C. After the termination of CPB, heparin was neutralized by protamine in a 1:1 ratio.
Autologous blood salvage (Brat-2, Sorin Group, Milan, Italy) was used during CPB to recover shed blood from the surgical field and after CPB to process blood from the extracoporeal circuit. Blood was suctioned (150 mm·Hg vacuum level) into a reservoir through a 120-μm filter. Cell processing occurred using a 250-mL Baylor bowl and the standard fill rate, wash rate, and wash volume recommended by the manufacturer. Intraoperatively, both allogeneic and autologous salvaged RBC units were administered to maintain hemoglobin concentration above 7 g/dL during CPB and above 8 g/dL after CPB. Postoperatively, hemoglobin concentration was maintained above 8 g/dL. Autologous salvaged RBCs, if available, were always given before stored allogeneic RBCs. Duration of allogeneic RBC storage was not controlled and was based on the usual practice at our institution.
All patients had radial artery catheters that were used for obtaining blood samples during and after surgery. Blood samples were drawn from the patient into heparinized syringes before incision, during CPB, on separation from CPB, at completion of surgery, and in the morning of postoperative days (POD) 1, 2, and 3. After the arterial catheter was removed (most often on POD 2), venous samples were obtained by phlebotomy. All blood samples were stored on ice and taken promptly (within 1 hour) to the laboratory where the measurements were performed.
Ektacytometry
RBC deformability and aggregation were measured with a microfluidic slit-flow ektacytometer (Rheo Meditech, Seoul, South Korea). The principle behind this measurement has been described in detail. 33 For deformability measurements, RBCs were suspended (final hematocrit approximately 0.5%) in a highly viscous polyvinylpyrrolidone solution (viscosity approximately 30 cP) with slow mixing and then loaded onto a sample reservoir of a microfluidic chip. During operation, a vacuum-generating mechanism allowed the sample to flow toward the waste reservoir through the micro-channel at a range of shear stresses (0.5 to 20.0 Pa), while the elliptical diffraction pattern of the flowing cells was generated by a laser beam (wavelength = 635 nm from a 1.5-mW laser diode) focused onto the microchannel. Deformability is expressed as the elongation index, which was defined as (L−W)/(L+W), where L and W are the major and minor axes of the ellipse, respectively, at various shear stress values. The elongation index values used for analysis were those measured at the shear stress level of 3 Pa, as suggested by Baskurt. 38 Higher elongation index values represent increased RBC cell membrane deformability.
RBC aggregation was measured with the same instrument but with a different cuvette and undiluted blood. The critical shear stress (measured in mPa) required to disperse RBCs was used to assess aggregation. Higher shear stress values represent greater RBC aggregation.
Data Analysis
We performed a sample size calculation based on previously collected RBC deformability data using the mean change in deformability attributed to stored allogeneic blood transfusion. 26 To detect a change in the elongation index of 0.2 ± 0.15 with an α of 0.05 and power of 0.8, the estimated sample size was 10 patients per study group.
For the primary analysis, we designated 3 groups of patients: autologous salvaged RBCs only (Auto group), autologous salvaged RBCs + minimal (<5 units) stored allogeneic RBC transfusion (Auto+Allo min group), and autologous salvaged RBCs + moderate (≥5 units) stored allogeneic RBC transfusion (Auto+Allo mod group). As in our previous study, 26 the a priori definition of minimal and moderate transfusion was <5 units and ≥5 units, respectively (approximately 1/2 total blood volume), administered over the course of the 3-day study period. A secondary analysis was also performed with patients analyzed as 2 groups: patients who received autologous salvaged RBCs alone (Auto, n = 12) and those who received autologous salvaged RBCs and any amount of stored allogeneic RBCs (Auto+Allo any, n = 20).
Differences in the mean measured values within groups and between groups were analyzed by 2-way repeated measures analysis of variance. The Tukey-Kramer HSD post hoc test was used to adjust for multiple comparisons of means, and Tukey-corrected P values are given. The statistical tests were predicated on the assumption of normal residuals and equal variance and covariance among groups. Dichotomous variables were analyzed by the χ 2 test. To assess the independent effects of CPB duration and quantity of blood transfused on change in RBC deformability, a multiple linear regression was performed with maximum posttransfusion change in elongation index as the dependent variable. CPB duration (minutes) and stored allogeneic blood (units) were the 2 (and only) independent variables in this regression. All data are presented as mean ± SD, and P < 0.05 was used to define significance.
RESULTS
Intraoperatively, all 32 patients received autologous salvaged RBCs. Twelve of these patients received autologous salvaged RBCs alone (Auto group). In addition to salvaged RBCs, 10 patients received 1 to 4 units of stored allogeneic RBCs (Auto+Allo min group), and 10 received 5 to 12 units of stored allogeneic RBCs (Auto+Allo mod group). The characteristics of these 3 groups of patients, including preoperative comorbid conditions, are shown in Table 1 . There were minimal differences among groups except for less peripheral vascular disease in the Auto+Allo min group. Table 2 shows the surgical and transfusion data, comparing the 3 groups. Patients who had revision sternotomy received larger amounts of stored allogeneic RBCs. The number of stored allogeneic RBC units transfused was significantly different among the 3 groups. Duration of CPB was significantly longer in the Auto+Allo mod group compared with the other 2 groups. Over the 3 PODs, only 1 patient who did not require intraoperative stored allogeneic blood received any postoperative stored allogeneic blood, and this patient (who received 3 postoperative units) was included in the Auto+Allo min group. The average duration of storage for the allogeneic blood was 24 ± 6 days, with a median of 25 days (range, 8-34 days). Forty-nine autologous salvaged RBC units and 86 stored allogeneic RBC units were transfused.
The assumptions that were made in performing the statistical analyses were satisfied after plotting histograms of the residuals, and comparison of variances and covariances to the means for the different groups. Figure 1 illustrates the 3-group comparison, which shows the changes in the RBC elongation index (deformability). Significant betweengroup differences were apparent at the end of CPB that persisted for the duration of the study and were still present on POD 3. There were also significant within-group changes in elongation index from baseline that persisted until POD 2 in the Auto+Allo min group, and for the duration of the study in the Auto+Allo mod group. Mean elongation index decreased in the Auto+Allo min group from the preincision baseline value of 32.31 ± 0.02 to a nadir of 30.47 ± 0.02 on POD 1 (P = 0.003), which is a 6% change. Mean elongation index in the Auto+Allo mod group decreased from 32.7 ± 0.02 (preincision baseline) to a nadir of 28.14 ± 0.01 on POD 1 (P < 0.0001), which is a 14% change. The Tukey-corrected P values revealed significant differences between the Auto and Auto+Allo min groups: after CPB (P = 0.03), end surgery (P = 0.008), POD 1 (P = 0.003), and POD 2 (P = 0.03). Likewise, corrected P values revealed significant differences between the Auto and Auto+Allo mod groups: after CPB (P = 0.004), end surgery (P = 0.006), POD 1 (P<0.0001), and POD 2 (P = 0.01), and POD 3 (P = 0.02). These findings illustrate a dose-response effect for decreased RBC deformability after transfusion with stored allogeneic blood.
Elongation index was significantly lower in patients who received any stored allogeneic blood (Auto+Allo any) than in those who did not (Auto) beginning at the end of CPB (Fig. 2) . This difference remained significant for the duration of the study. Mean elongation index decreased in the the Auto+Allo group from a preincision baseline value of 32.46 ± 0.02 to a nadir of 29.56 ± 0.01 on POD 1 (P = 0.003), which is a 9% change. The Tukey-corrected P values revealed significant differences between the Auto and Auto+Allo any groups: after CPB (P = 0.04), end surgery (P = 0.01), POD 1 (P = 0.003), and POD 2 (P = 0.02) and POD 3 (P = 0.03). The Auto group exhibited no significant changes from the preincision baseline value at any time during the study.
Since longer duration of CPB was necessary in the patients who received the largest amount of stored allogeneic transfused blood, a multiple linear regression was used to assess both these variables as independent predictors of changes in deformability. The results of this analysis showed that the total number of units of stored allogeneic blood transfused was a significant independent predictor of maximum posttransfusion change in RBC deformability (P = 0.004), but CPB duration was not (P = 0.52). Figure 3 shows the changes in RBC critical shear stress (aggregation) over time for the 3 groups. No differences were observed among groups, but with all patients in the 3 groups combined, aggregation decreased to a nadir at the end of surgery and returned to baseline by POD 1. The mean critical shear stress value for all patients combined decreased from a preincision baseline of 359 ± 174 mPa to a nadir of 170 ± 141 mPa at the end of surgery (P = 0.01, Tukeycorrected), which is a 54% change. Figure 4 shows a similar comparison of changes in RBC critical shear stress between the Auto and Auto+Allo any groups. Again, there were no between-group differences at any time point, but values for both groups combined were significantly decreased at the end of CPB Tukey-corrected P = 0.01) and returned to baseline by POD 1.
DISCUSSION
In this study, CPB combined with autologous salvaged RBC transfusion was not associated with changes in RBC deformability. In contrast, stored allogeneic RBC transfusion was associated with a dose-dependent loss of RBC deformability. The reversal of these changes was also dose-dependent, with return to baseline by POD 3 when the patients received <5 units of stored blood but incomplete reversal by POD 3 after ≥5 units of transfused blood. The decrease in RBC aggregation associated with CPB was unrelated to transfusion. It returned to baseline by POD 1 and never increased above baseline measurements. These findings suggest that fresh autologous salvaged RBCs may be of higher quality than stored allogeneic RBCs regarding cell membrane deformability, an important determinant of blood flow in the microcirculation and thus of tissue oxygen delivery. 31, 35, 39, 40 The possibility that deformability of stored RBCs is impaired in a dose-dependent fashion may in part explain previous findings that the incidence of adverse outcomes is higher in patients who receive larger amounts of stored blood. 4, 11, 41 If the laboratory-measured changes in our study do have clinical relevance, our findings would support the use of fresh autologous salvaged blood when possible, rather than stored allogeneic blood, especially when storage duration is prolonged.
Abundant evidence suggests that stored allogeneic transfused RBCs are functionally impaired relative to fresh circulating endogenous RBCs. 16, 26, 32, 42, 43 Evidence also indicates that CPB adversely affects RBC structure and function, [23] [24] [25] and 1 study has shown functional changes in salvaged autologous RBCs tested in vitro but not in blood sampled from patients after salvaged blood transfusion. 44 In our study, we found that neither salvaged RBCs nor CPB, when studied in combination, had a detrimental effect on RBC deformability. It is of note that earlier studies showing a 50% to 60% loss of deformability with CPB were performed with older technology, such as bubble oxygenators, that have been implicated in RBC damage and loss of deformability. 23, 29 In the current study, all patients had CPB with membrane oxygenators, which have been shown to preserve RBC function without causing loss of deformability. 30 One particular limitation of previous research into the effects of CPB is lack of information on whether the patients received allogeneic transfusion. 23, 25, 29 Thus, one cannot exclude the possibility that transfusion of stored RBCs confounds the effects of CPB on RBC deformability. Figure 2 . Red blood cell (RBC) deformability, represented as the elongation index measured by ektacytometry, is compared between 2 groups. In patients who received autologous salvaged RBCs only, elongation index did not change from baseline over the 3-day study period. For patients who received autologous salvaged RBCs and any amount of stored allogeneic RBCs, the mean elongation index decreased by 9% (P = 0.001), reached a nadir on postoperative day (POD) 1, and remained significantly lower than baseline until POD 3. Auto = autologous salvaged RBCs only; Auto+Allo any = autologous salvaged RBCs and any amount of stored allogeneic RBCs; CPB = cardiopulmonary bypass. *P < 0.05 for between-group differences; #P < 0.05 for within-group difference from preincision baseline.
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RBC Characteristics and Cardiac Surgery Patients Figure 3 . Red blood cell (RBC) aggregation, represented as the critical shear stress measured by ektacytometry, is compared in the 3 groups. Critical shear stress did not differ among the transfusion groups, but the changes within groups were significant. For all groups, critical shear stress decreased significantly by the end of cardiopulmonary bypass (CPB) and returned to baseline levels by postoperative day (POD) 1. These findings indicate a transient, reversible decrease in RBC aggregation associated with CPB that is unrelated to transfusion. Auto = autologous salvaged RBCs only; Auto+Allo min = autologous salvaged RBCs + minimal (<5 units) stored allogeneic RBCs; Auto+Allo mod = autologous salvaged RBCs + moderate (≥5 units) stored allogeneic RBCs. #P < 0.05 for within-group difference from preincision baseline. Figure 4 . Red blood cell (RBC) aggregation, represented as the critical shear stress measured by ektacytometry, is compared in 2 groups. Critical shear stress did not differ between transfusion groups, but the changes within groups were significant. For both groups, critical shear stress decreased significantly by the end of cardiopulmonary bypass (CPB) and returned to baseline levels by postoperative day (POD) 1. These findings indicate a transient, reversible decrease in RBC aggregation associated with CPB that is unrelated to transfusion. Auto = autologous salvaged RBCs only; Auto+Allo any = autologous salvaged RBCs and any amount of stored allogeneic RBCs.#P < 0.05 for within-group difference from preincision baseline.
Although the storage lesion with allogeneic blood has been well described, it is unclear whether the various detrimental changes that RBCs undergo during storage are reversible after transfusion. The loss of 2,3-diphosphoglycerate, for example, is thought to return to baseline levels by 2 or 3 days after transfusion. 45 Although nitric oxide is rapidly depleted during RBC storage, 42 it is controversial whether repletion occurs after transfusion, and how quickly the levels return to baseline. 14, 46 Some data suggest that the decrease in RBC cell membrane deformability is irreversible, 26 but the evidence is insufficient to clearly answer the question. Our findings suggest that the effect of allogeneic blood transfusion is dose dependent, and that when large amounts of stored RBCs are administered; the loss of deformability may persist for as long as 3 days, although the data did show a trend toward return to baseline. Of course, it remains to be determined whether statistically significant changes in ektacytometry measurements reflect a clinically significant loss in overall RBC function.
In contrast to RBC deformability, little is known about the effects of CPB on RBC aggregation. CPB has been associated with a transient decrease in RBC aggregation, as shown in a study that compared patients who had undergone cardiac surgery either "on-pump" or "off-pump." 25 Although this particular study comprehensively measured changes in RBC morphology and aggregation (by 2 different methods), the authors provided no information on whether the patients were transfused. However, the findings regarding changes in aggregation were very similar to ours, with a transient decrease during CPB and return to baseline levels within 48 hours. Other investigators have shown that RBC aggregation in processed autologous salvaged blood, both before and after transfusion, is associated with no changes in aggregation. 44 The changes that we measured were a transient decrease in aggregation that returned to baseline values by POD 1. We found no evidence of increased aggregation above baseline levels at any time point, an event that has been implicated in reduced blood flow in the microcirculation. 47 Potential limitations in this study include the following. Because no patients had CPB without RBC transfusion, we are unable to comment about the effects of CPB alone on RBC characteristics. As autologous blood salvage has become routine practice for most cardiac surgical procedures, the 3 groups in our study likely represent the most common clinical scenarios, making our study design clinically relevant. A second limitation is that no patients received stored allogeneic RBCs in the absence of autologous salvaged RBCs. This scenario would also be uncommon, so again, the findings we report are most clinically relevant when considering routine practice. Another limitation is the potential confounding effect of longer-duration CPB in the Auto+Allo mod group. Hence, we cannot definitively state that the adverse changes in RBC deformability were attributable to increased transfusion. If CPB is harmful to RBC function, it is possible that confounding occurred, but we can conclude that the combination of prolonged CPB and increased stored blood transfusion appear to be detrimental. Although not definitive, the results of our multivariate analysis suggest that duration of CPB has less effect on RBC cell membrane deformability, compared with the effect of stored allogeneic blood transfusion. Last, our findings might have been different had we transfused allogeneic RBCs with shorter storage durations. The 24-day average duration of storage for blood administered in our study would be considered "older" blood according to the criteria used in the RECESS 48 and ABLE 49 studies, 2 ongoing clinical trials designed to compare outcomes in patients who receive RBCs with shorter or longer duration of storage.
In summary, for patients undergoing cardiac surgery with CPB, transfusion of salvaged autologous RBCs alone had no demonstrable adverse effect on RBC deformability or aggregation. When stored allogeneic RBCs were transfused, RBCs exhibited dose-dependent detrimental changes in deformability and a dose-dependent reversal of these changes. We also observed a transient decrease in RBC aggregation after CPB that was unrelated to transfusion. Our findings may have clinical implications for some patients, because transfusion of stored blood may not achieve the desired effect, namely improved oxygen delivery and improved outcome. In addition, the detrimental changes in RBC quality associated with storage may also explain the failure to show benefit in clinical trials that use stored allogeneic blood with a liberal transfusion strategy. E
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